» Articles » PMID: 38671262

LPCAT1-mediated Membrane Phospholipid Remodelling Promotes Ferroptosis Evasion and Tumour Growth

Abstract

The mechanisms underlying the dynamic remodelling of cellular membrane phospholipids to prevent phospholipid peroxidation-induced membrane damage and evade ferroptosis, a non-apoptotic form of cell death driven by iron-dependent lipid peroxidation, remain poorly understood. Here we show that lysophosphatidylcholine acyltransferase 1 (LPCAT1) plays a critical role in ferroptosis resistance by increasing membrane phospholipid saturation via the Lands cycle, thereby reducing membrane levels of polyunsaturated fatty acids, protecting cells from phospholipid peroxidation-induced membrane damage and inhibiting ferroptosis. Furthermore, the enhanced in vivo tumour-forming capability of tumour cells is closely associated with the upregulation of LPCAT1 and emergence of a ferroptosis-resistant state. Combining LPCAT1 inhibition with a ferroptosis inducer synergistically triggers ferroptosis and suppresses tumour growth. Therefore, our results unveil a plausible role for LPCAT1 in evading ferroptosis and suggest it as a promising target for clinical intervention in human cancer.

Citing Articles

Identification of Prognostic Genes Related to Cell Senescence and Lipid Metabolism in Glioblastoma Based on Transcriptome and Single-Cell RNA-Seq Data.

Li Q, Liu H Int J Mol Sci. 2025; 26(5).

PMID: 40076502 PMC: 11899969. DOI: 10.3390/ijms26051875.


HIF-2α/LPCAT1 orchestrates the reprogramming of lipid metabolism in ccRCC by modulating the FBXW7-mediated ubiquitination of ACLY.

Fei M, Zhang Y, Li H, Xu Q, Gao Y, Yang C Int J Biol Sci. 2025; 21(2):614-631.

PMID: 39781455 PMC: 11705634. DOI: 10.7150/ijbs.103032.


Mechanism of ferroptosis resistance in cancer cells.

Wang Y, Yu G, Chen X Cancer Drug Resist. 2024; 7:47.

PMID: 39624080 PMC: 11609146. DOI: 10.20517/cdr.2024.127.


Ferroptosis: mechanisms and therapeutic targets.

Zhou Q, Meng Y, Le J, Sun Y, Dian Y, Yao L MedComm (2020). 2024; 5(12):e70010.

PMID: 39568772 PMC: 11577302. DOI: 10.1002/mco2.70010.


NFE2L2 and ferroptosis resistance in cancer therapy.

Tang D, Kang R Cancer Drug Resist. 2024; 7:41.

PMID: 39534872 PMC: 11555182. DOI: 10.20517/cdr.2024.123.


References
1.
van Meer G, Voelker D, Feigenson G . Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol. 2008; 9(2):112-24. PMC: 2642958. DOI: 10.1038/nrm2330. View

2.
Wang B, Tontonoz P . Phospholipid Remodeling in Physiology and Disease. Annu Rev Physiol. 2018; 81:165-188. PMC: 7008953. DOI: 10.1146/annurev-physiol-020518-114444. View

3.
Hazel J, Williams E . The role of alterations in membrane lipid composition in enabling physiological adaptation of organisms to their physical environment. Prog Lipid Res. 1990; 29(3):167-227. DOI: 10.1016/0163-7827(90)90002-3. View

4.
Doll S, Proneth B, Tyurina Y, Panzilius E, Kobayashi S, Ingold I . ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2016; 13(1):91-98. PMC: 5610546. DOI: 10.1038/nchembio.2239. View

5.
Dixon S, Winter G, Musavi L, Lee E, Snijder B, Rebsamen M . Human Haploid Cell Genetics Reveals Roles for Lipid Metabolism Genes in Nonapoptotic Cell Death. ACS Chem Biol. 2015; 10(7):1604-9. PMC: 4509420. DOI: 10.1021/acschembio.5b00245. View